Cantor Fitzgerald Remains Bullish on Bellicum Pharma (BLCM) Following 4Q
Tweet Send to a Friend
Cantor Fitzgerald reiterated an Overweight rating and $32.00 price target on Bellicum Pharmaceuticals (NASDAQ: BLCM) following the company's 4Q earnings ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
